Company profile for Cassava Sciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a clinical-stage biopharmaceutical company focused on neuroscience. We translate novel scientific insights into new medicines. That’s a drastic challenge. Our work is complex, risky, labor-intensive, persistent and expensive. And it’s what we love to do. A key focus of our R&D is to develop first-in-class medicines for people with debilitating neurodegenerative conditions. In fact, Our mission is to de...
We are a clinical-stage biopharmaceutical company focused on neuroscience. We translate novel scientific insights into new medicines. That’s a drastic challenge. Our work is complex, risky, labor-intensive, persistent and expensive. And it’s what we love to do. A key focus of our R&D is to develop first-in-class medicines for people with debilitating neurodegenerative conditions. In fact, Our mission is to detect and treat Alzheimer's disease. What if detecting Alzheimer’s was as simple as getting a blood test? We’re working on that too.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
7801 N. Capital of Texas Highway Suite 260 Austin, TX 78731
Telephone
Telephone
(512) 501 - 2444
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/12/3186208/8339/en/Cassava-Reports-Q3-2025-Financials-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/10/22/3171014/8339/en/Cassava-Sciences-Appoints-Dawn-C-Bir-to-the-Board-of-Directors.html

GLOBENEWSWIRE
22 Oct 2025

https://www.globenewswire.com/news-release/2025/10/14/3166098/0/en/Lexicon-Pharmaceuticals-Presents-Additional-Pilavapadin-Data-in-Diabetic-Peripheral-Neuropathic-Pain-at-19th-Annual-Pain-Therapeutics-Summit.html

GLOBENEWSWIRE
14 Oct 2025

https://www.globenewswire.com/news-release/2025/08/25/3138397/8339/en/Cassava-Sciences-to-Participate-in-the-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html

GLOBENEWSWIRE
25 Aug 2025

https://www.globenewswire.com/news-release/2025/08/14/3133350/8339/en/Cassava-Reports-Q2-2025-Financials-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
14 Aug 2025

https://www.globenewswire.com/news-release/2025/08/04/3126466/8339/en/Cassava-Sciences-Reports-Positive-Preclinical-Study-Evaluating-Simufilam-for-TSC-Related-Epilepsy.html

GLOBENEWSWIRE
04 Aug 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty